362703-35-3

Basic information

• Product Name: METHYL 4-AMINOMETHYL-1-BOC-PIPERIDINE-4-CARBOXYLATE
• Synonyms: Methyl 4-aminomethyl-1-Boc-piperidine-4-carboxylate;1,4-Piperidinedicarboxylic acid, 4-(aMinoMethyl)-, 1-(1,1-diMethylethyl) 4-Methyl ester;Methyl 1-Boc-4-aMinoMethylpiperidine-4-carboxylate;1-tert-Butyl 4-methyl 4-(aminomethyl);piperidine-1,4-dicarboxylate;O1-tert-Butyl O4-methyl 4-(aminomethyl)piperidine-1,4-dicarboxylate
• CAS NO: 362703-35-3
• Molecular Formula: C₁₃H₂₄N₂O₄
• Molecular Weight: 272.34
• Mol File: 362703-35-3.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 353.6 °C at 760 mmHg
• Flash Point: 167.7 °C
• Appearance: /
• Density: 1.109g/cm³
• Vapor Pressure: 3.55E-05mmHg at 25°C
• Refractive Index: 1.486
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: METHYL 4-AMINOMETHYL-1-BOC-PIPERIDINE-4-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-AMINOMETHYL-1-BOC-PIPERIDINE-4-CARBOXYLATE(362703-35-3)
• EPA Substance Registry System: METHYL 4-AMINOMETHYL-1-BOC-PIPERIDINE-4-CARBOXYLATE(362703-35-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 362703-35-3(Hazardous Substances Data)

Usage

General Description

Methyl 4-aminomethyl-1-boc-piperidine-4-carboxylate is a chemical compound with the molecular formula C13H23NO4. It is a derivative of Boc-protected piperidine, and is commonly used as a building block in organic synthesis and medicinal chemistry. The compound is characterized by the presence of a piperidine ring structure, which is a common motif in many pharmaceuticals and biologically active compounds. Methyl 4-aminomethyl-1-boc-piperidine-4-carboxylate is most commonly used as a precursor in the synthesis of various pharmaceuticals and fine chemicals, due to its versatile reactivity and functional group compatibility.

InChI:InChI=1/C13H24N2O4/c1-12(2,3)19-11(17)15-7-5-13(9-14,6-8-15)10(16)18-4/h5-9,14H2,1-4H3

Upstream product

• 91419-52-2 1-tert-butoxycarbonyl-4-cyanopiperidine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1016258-66-4 1-(tert-butyl) 4-ethyl 4-cyanopiperidine-1,4-dicarboxylate 
• 4395-98-6 4-cyanopiperidine 
• 159635-50-4 Bis-(2-bromo-ethyl)-carbamic acid tert-butyl ester 
• 362703-34-2 1-tert-butyl 4-methyl 4-cyanopiperidine-1,4-dicarboxylate 

Downstream Products

• 362703-36-4 4-{[4-(2-methyl-quinolin-4-ylmethoxy)-benzoylamino]-methyl}-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-methyl ester 
• 1338251-86-7 C₂₅H₃₂N₂O₆ 
• 1338251-87-8 C₂₅H₃₂N₂O₆ 
• 1338251-88-9 C₂₅H₃₂N₂O₆ 
• 1338251-89-0 C₂₅H₂₉F₃N₂O₅ 
• 1338251-90-3 C₂₅H₂₉F₃N₂O₅ 
• 1338251-91-4 C₂₅H₂₉F₃N₂O₅ 
• 1338251-92-5 C₂₉H₃₆N₂O₆ 
• 1338251-93-6 C₂₅H₃₂N₂O₅ 
• 1338251-94-7 C₂₃H₂₆Cl₂N₂O₄ 
• 1338251-95-8 C₂₃H₂₆Cl₂N₂O₄ 
• 1338251-96-9 C₂₃H₂₆Cl₂N₂O₄ 
• 1338251-97-0 C₂₃H₂₃Cl₂F₃N₂O₃ 
• 1338251-98-1 C₂₃H₂₃Cl₂F₃N₂O₃ 

Relevant articles and documents

LIM KINASE INHIBITORS

The present invention relates to new kinase inhibitors, more specifically LIM Kinase inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and Prophylaxis of disease. In particular, the present invention relates to new LIMK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and Prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said Compounds in the manufacture of a medicament for the application to a number of therapeutic indications including Ophthalmic and intestinal diseases.

Synthesis and structure-activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors

A novel series of achiral TNF-α converting enzyme (TACE) inhibitors has been discovered. These compounds exhibited activities from 0.35 to 11 nM in a porcine TACE assay and inhibited TNF-α production in an LPS-stimulated whole blood assay with an IC5